With the election just a day away, each of the three major political parties have revealed the policies they believe will affect, enhance and support the life science market, at MedilinkUK.com.
The Liberal Democrats will be investing in schools to promote future scientists and their belief in the importance of science investment to economic recovery. By encouraging universities to work more closely with businesses, particularly SMEs, the Liberal Democrats hope to combine the technical knowledge of academics with the business experience of local entrepreneurs to support the creation of new mechanisms to provide smaller businesses with access to equity.
The Conservatives pledge to implement key recommendations from Sir James Dyson's Review into how to achieve its goal of making Britain Europe's leading hi-tech exporter, as well as improve and refocus research and development tax credits on hi-tech companies, small businesses and new start-ups. To boost small businesses and life sciences start-ups, the party promises to deliver 25 per cent of government research and procurement contracts through SMEs by cutting the administrative costs of bidding.
Labour plans to encourage life science businesses to benefit from the introduction of the ‘Patent Box', which will apply a 10 per cent rate of corporation tax to income received from UK patents to ensure the UK that remains an attractive location for innovation. The Innovation Investment Fund will back entrepreneurs who need capital for their businesses to grow. Financed by £325m of government investment and private venture capital, the fund will support the next generation of technology-based businesses.
Members of the Life Science community will be debating these key issues at MedilinkUK.com
MedilinkUK.com features content and topics specifically tailored to the pharmaceuticals, medical biotechnology and medical technology markets, but delivers a balanced overview of the sector's issues. The life sciences industry is defined as the study of human biology and the application of technology to that science. Recognised markets within life sciences are medical technology, medical biotechnology and pharmaceuticals.
MedilinkUK.com, which has the backing of the Office for Life Sciences (OLS), is the first place industry voices its concerns and raises the issues that really matter. Bringing together business leaders, public and private sector employees, entrepreneurs, academics, trade associations and scientists, the site is a natural evolution of the original and successful ‘Voices of Industry' campaign run by MedilinkWM.
